BCAL Diagnostics Limited (BDX.AX)
AUD 0.09
(-2.17%)
AUD 0.09
(-2.17%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -5.66 Million AUD | 26.62% |
| 2023 | -7.72 Million AUD | -90.64% |
| 2022 | -4.06 Million AUD | -126.84% |
| 2021 | -1.79 Million AUD | -59.21% |
| 2020 | -1.03 Million AUD | -66.39% |
| 2019 | -677.84 Thousand AUD | 1.55% |
| 2018 | -690.25 Thousand AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | -1.85 Million AUD | 52.85% |
| 2024 Q2 | -3.94 Million AUD | -304.78% |
| 2024 FY | - AUD | -13.28% |
| 2024 Q1 | -974.13 Thousand AUD | 77.81% |
| 2024 Q4 | -1.85 Million AUD | 0.0% |
| 2023 FY | - AUD | -90.64% |
| 2023 Q4 | -1.14 Million AUD | 0.82% |
| 2023 Q3 | -1.15 Million AUD | 2.05% |
| 2023 Q2 | -1.18 Million AUD | 0.0% |
| 2023 Q1 | -1.18 Million AUD | -20.04% |
| 2022 Q3 | -978.88 Thousand AUD | 43.27% |
| 2022 FY | - AUD | -126.84% |
| 2022 Q2 | -1.72 Million AUD | -1299.94% |
| 2022 Q1 | -123.26 Thousand AUD | 91.67% |
| 2022 Q4 | -984.04 Thousand AUD | -0.53% |
| 2021 Q4 | -1.48 Million AUD | -332.02% |
| 2021 FY | - AUD | -59.21% |
| 2021 Q1 | -120.41 Thousand AUD | -23.08% |
| 2021 Q2 | -319.77 Thousand AUD | -165.56% |
| 2021 Q3 | -342.68 Thousand AUD | -7.17% |
| 2020 Q3 | -98.87 Thousand AUD | 60.06% |
| 2020 Q1 | -247.53 Thousand AUD | 0.0% |
| 2020 Q4 | -97.83 Thousand AUD | 1.06% |
| 2020 Q2 | -247.53 Thousand AUD | 0.0% |
| 2020 FY | - AUD | -66.39% |
| 2019 FY | - AUD | 1.55% |
| 2018 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Australian Clinical Labs Limited | 181.83 Million AUD | 103.116% |
| Genetic Signatures Limited | -20.33 Million AUD | 72.137% |
| Genetic Technologies Limited | -11.43 Million AUD | 50.425% |
| Healius Limited | -298.09 Million AUD | 98.099% |
| Imagion Biosystems Limited | -13.69 Million AUD | 58.627% |
| Integral Diagnostics Limited | 12.33 Million AUD | 145.945% |
| INOVIQ Ltd | -6.63 Million AUD | 14.571% |
| Microba Life Sciences Limited | -22.8 Million AUD | 75.155% |
| Monash IVF Group Limited | 13.02 Million AUD | 143.507% |
| Rhythm Biosciences Limited | -6.79 Million AUD | 16.614% |
| Sonic Healthcare Limited | 1.65 Billion AUD | 100.342% |